Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JDP-205 PK and Safety in Healthy Volunteers
NCT02024152Phase 1Completed
- Sponsor
- JDP Therapeutics
- Start
- Mar 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cetirizine hydrochloride in acute urticaria, sponsored by JDP Therapeutics. Started Mar 2011; status: completed.
02
Drugs
cetirizine hydrochloride
03
Conditions
acute urticaria
Beyond the preview
Go deeper on NCT02024152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02024152.